baber/WOPTO huggingface dataset:
Patent NZ-214661-A (NZ)
Title: Tetrahydro benzothiazole derivatives and pharmaceutical compositions
Inventor: GRISS GERHART
IPC: C07D277/82
Filed: 1985-12-20
Abstract: This invention relates to new tetrahydrobenzthiazoles of general formula    <IMAGE>  (I)  wherein R1 represents a hydrogen atom, an alkyl group, an alkenyl or alkynyl group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the above mentioned phenyl nucleic may each be substituted by 1 or 2 halogen atoms, R2 represents a hydrogen atom or an alkyl group, R3 represents a hydrogen atom, an alkyl group a cycloalkyl group, an alkenyl or alkynyl group, an alkanoyl group, a phenyl alkyl or phenyl alkanoyl group, while the phenyl nucleus may be substituted by fluorine, chlorine or bromine atoms, R4 represents a hydrogen atom, an alkyl group, an alkyl or alkenyl group, or R3 and R4 together with the nitrogen atom between them represent a pyrrolidino, piperidino, hexamethyleneimino or morpholino group, the enantiomers and the acid addition salts thereof. The compounds of general formula I above in which one of the groups R1 or R3 or both groups R1 and R3 represent an acyl group are valuable intermediate products for preparing the other compounds of general formula I which have valuable pharmacological properties. The new compounds may be prepared using methods known per se.
Patent NZ-215867-A (NZ)
Title: Aids envelope protein, dna vectors and method of production
Inventor: CROWL R M
IPC: C12N15/00
Filed: 1986-04-17
Abstract: Recombinant envelope proteins of the etiologic agent of acquired immune deficiency syndrome (AIDS) useful in diagnosis and therapy of AIDS and a method for their preparation are described. Proviral DNA is transferred into a host cell after engineering into an expression vector which produces the envelope protein. A method of testing human blood for the presence of antibodies to the AIDS virus using the AIDS envelope protein is also described.
Patent NZ-218806-A (NZ)
Title: 1-arylpyrazoles and pesticidal compositions
Inventor: JENSEN-KORTE U
IPC: C07D231/18
Filed: 1987-01-06
Abstract: Insecticidally active 1-aryl-pyrazoles of the formula   <IMAGE>   in which R1 represents hydrogen, alkyl or haloalkyl, R2 represents alkyl, alkenyl, alkinyl, cycloalkyl, haloalkyl, haloalkenyl, alkoxyalkyl, alkylthioalkyl, alkylsulphinylalkyl, alkylsulphonylalkyl, optionally substituted aralkyl or optionally substituted aryl, R3 represents alkyl, haloalkyl, cycloalkyl or optionally substituted aryl, Ar represents subsituted phenyl, with the exception of the 4-nitrophenyl radical or the 2,4-dinitrophenyl radical, or represents optionally substituted pyridyl, and n represents a number 0, 1 or 2.
Patent NZ-223411-A (NZ)
Title: Cyclopropane ester and biocidal composition
Inventor: CADIERGUE J
IPC: C07F7/18
Filed: 1988-02-04
Abstract: Compounds of formula I: 
<IMAGE>
 in which:
 - X denotes a hydrogen, fluorine, chlorine or bromine atom,
 - R denotes an alkyl, aryl or heterocyclic radical,
 - Z denotes a hydrogen atom, a CH3 radical, C N or C CH, and
 - Y denotes a hydrogen atom or an alkyl, -(CH2)m-O-alkyl, -(CH2)m-S- alkyl, (CH2)m-N-(alkyl)2 or Si(alkyl)3 radical. 
<??>The compounds of formula I exhibit advantageous pesticidal properties.
Patent NZ-229499-A (NZ)
Title: Imidazo(1,5-a)quinoxaline derivatives and pharmaceutical compositions
Inventor: HANSEN HOLGER CLAUS
IPC: C07D487/04
Filed: 1989-06-12
Abstract: New imidazoquinoxaline compounds having the general formula <CHEM>  wherein  R<3> is <CHEM>  or CO2R min  wherein R min  is C1-6-alkyl, which may be straight or branched, C3-7-cycloalkyl or phenyl; and  R<4> is hydrogen or C1-6-alkyl; and 5-N-oxides thereof. The compounds are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics, hypnotics, and in improving the cognitive function of the brain of mammals.
Patent NZ-240550-A (NZ)
Title: Telephone line unit with common logic and programmable rom
Inventor: SANDERS GUS CLINT
IPC: H04B3/03
Filed: 1991-11-12
Abstract: A line unit, used in a line shelf having a line shelf processor and common logic, is provided with an EEPROM device for storing information relative to the line unit. The stored information includes line unit type identification codes, auto provisioning data, gain and equalization adjustment data and signaling translation tables. The data contained within the EEPROM may be utilized by the line shelf processor to provide automatic initialization and provisioning of the line unit when first inserted into the line shelf, and automatic signaling translation so that line unit signaling becomes compatible with a transmission facility connected to the line shelf. The need for factory preset resistors installed in the line unit may be eliminated by storing within the EEPROM a required gain setting. <IMAGE>
Patent NZ-244034-A (NZ)
Title: Peptides with growth hormone releasing activity (5-8 aas) and synergistic methods promoting growth hormone levels, using them together with growth hormone releasing hormones and their functional equivalents
Inventor: BOWERS CYRIL YARLING
IPC: A61K38/08
Filed: 1992-08-20
Abstract: Novel peptides of the formula A1-A2-Ala-Trp-DPhe-A5 are disclosed which promote the release of growth hormone when administered to animals. These peptides can be used therapeutically.
Patent NZ-248600-A (NZ)
Title: Drug delivery nebuliser: drug aerosol introduced only during inhalation phase
Inventor: DENYER JONATHAN STANLEY HAROLD
IPC: A61M11/02
Filed: 1993-09-07
Abstract: An arrangement for delivering a drug aerosol comprises a sensor (3) which detects turbulent air flow during inhalation and causes the nebulizer (8,9,10,11,12,13) to generate the aerosol only during the inhalation phase of the breathing cycle. Airflow is diverted from the sensor during exhalation. <IMAGE>
Patent NZ-256446-A (NZ)
Title: Esterification of 13-alpha-hydroxytaxol derivatives using a 4-aryl-5-carboxyoxazolidine with subsequent ring opening; intermediates and taxol derivatives
Inventor: COMMERCON ALAIN
IPC: A61K31/421
Filed: 1993-10-04
Abstract: PCT No. PCT/FR93/00968 Sec. 371 Date Apr. 4, 1995 Sec. 102(e) Date Apr. 4, 1995 PCT Filed Oct. 4, 1993 PCT Pub. No. WO94/07878 PCT Pub. Date Apr. 14, 1994Method of preparing taxane derivatives of general formula (I) by esterification of protected baccatine III or 10-deacetyl-baccatine III by means of an acid of general formula (VII), deprotection of the side chain and elimination of the hydroxy function protection groupings. In general formulae (I) and (VII): Ar stands for aryl, R is hydrogen or acetyl, R1 is benzoyl or R2-O-CO- in which R2 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl, and R3 is hydrogen, alkoxy, optionally substituted aryl.    <IMAGE>  (I)   <IMAGE>  (VII)
Patent NZ-268270-A (NZ)
Title: Titanium (ii)- or zirconium (ii)- containing complexes and addition polymerisation catalysts therefrom (m is ti or zr)
Inventor: DEVORE DAVID D
IPC: C07F/
Filed: 1994-06-16
Abstract: Novel catalytic derivatives of titanium or zirconium complexes containing one and only one cyclic delocalized, anionic, +529 -bonded group wherein the metal is in the +2 formal oxidation state and having a bridged ligand structure and an activating cocatalyst are useful as catalysts for polymerizing olefins, diolefins and/or acetylenically unsaturated monomers.
Patent NZ-270088-A (NZ)
Title: Antiviral medicaments containing a quinoxaline and a nucleoside derivative
Inventor: MEICHSNER CHRISTOPH
IPC: C08G61/12
Filed: 1994-12-07
Abstract: A combination product containing at least one nucleoside and a compound of the formulae I and/or Ia, <IMAGE> or the physiologically tolerated salts thereof, where the symbols X and n, and the substituents R<1>-R<5>, have the stated meanings, display antiviral activity.
Patent NZ-271041-A (NZ)
Title: Container closure; comprises a two portion sealing rib projecting downwards from the underside of the top
Inventor: TANSEY CHARLES MARTIN
IPC: B65D53/02
Filed: 1994-08-19
Abstract: PCT No. PCT/AU94/00486 Sec. 371 Date Feb. 15, 1996 Sec. 102(e) Date Feb. 15, 1996 PCT Filed Aug. 19, 1994 PCT Pub. No. WO95/05321 PCT Pub. Date Feb. 23, 1995A closure for a container having a two portion sealing rib projecting downwardly form the underside of the top. The first portion of the rib being contiguous with the top and the second portion being frusto-conical and contiguous with the end of the first portion and extending radially inwardly to terminate in a circular free edge. The upper surface of the second portion has an engagement means comprising a continuous annular ridge which engages with the underside of the top of the closure which in turn has a continuous annular ridge positioned inwardly and adjacent the first portion of the sealing rib. A closure for a carbonated liquid container having a sealing means which has attached thereto an abutment which will firmly engage with the thread on a neck of container if the closure is over-torqued thereby preventing missiling of the closure off the container.
Patent NZ-290689-A (NZ)
Title: Antibodies which activate an erythropoetin receptor
Inventor: ELLIOTT STEVEN G
IPC: A61K39/00
Filed: 1995-07-26
Abstract: Antibodies and fragments thereof which activate an erythropoietin receptor and stimulate erythropiesis are described. Also described are hybridoma cell lines which produce the antibodies and methods and compositions for the treatment of anemia. <IMAGE>
Patent NZ-331164-A (NZ)
Title: Vaccines against varicella zoster virus gene 63 product
Inventor: RENTIER BERNARD
IPC: A61P37/04
Filed: 1997-02-04
Abstract: A composition for the treatment or prevention of Zoster of individuals infected with Varicella Zoster virus (VZV), and to the prevention and treatment of Varicella infections. The compositions of the invention comprise the protein encoded by VZV gene 63 or an immunologically active derivative thereof. The invention further relates to compositions containing DNA or RNA corresponding to VZV gene 63.
Patent NZ-336400-A (NZ)
Title: Printed polymeric film having a surface polymeric layer which is chemically or oxidatively unprimed
Inventor: HSU CHIEN-LU
IPC: G03G9/12
Filed: 1998-01-20
Abstract: The printed thermoplastic packaging material comprises: a)	a flexible thermoplastic packaging film comprising a surface polymeric layer and b)	on the  surface polymeric layer, a printed image derived from a toner.  The surface polymeric layer is chemically and oxidatively unprimed and comprising as its primary component a thermoplastic polymer having at least one of a melting point and Vicat softening point of no more than about 130oC.  A package can be formed by sealing the above packaging material.
Patent NZ-503226-A (NZ)
Title: Joining device for a flexible cord using a sheath
Inventor: POWELL KERRY JOHN
IPC: F16G11/02
Filed: 2000-03-07
Abstract: A connecting device (1) for joining an electric fence comprising an attachment member having two ends. At one end, there is provided at least two hooks or the like attaching members capable of engaging a cord media and at the opposite end, a means for attaching. There is also a contact area between said at least two hooks or the like attaching members (4) and a sheath (2). The said hooks (4) have an open mouth to receive said cord media (5) and a crown (7) to retain the cord media against. Also, the sheath (2) is said to be able to fit over said attachment member (4) when said attachment member (4) is engaged with said cord media (5) to cause the hooks to come into close proximity to one another to provide a contact area with said cord media therebetween.
Patent NZ-504870-A (NZ)
Title: Triazolo-pyridazine derivatives as ligands for gaba receptors
Inventor: GUIBLIN ALEXANDER RICHARD
IPC: A61P25/00
Filed: 1999-01-13
Abstract: A compound of formula (I), wherein Z represents trifluoromethyl, 2-methylpropyl, 2,2-dimethylpropyl, 3-methylbutyl, 1-fluorobut-3-enyl, cyclobutyl, 1-methylcyclobutyl, 1-fluorocyclobutyl, 3-fluorocyclobutyl, 3,3-difluorocyclobutyl, 3hydroxycyclobutyl, 3-benzyloxycyclobutyl, 3-oxocyclobutyl, 1-methylcyclohexyl, 4,4-difluoro-1-methylcyclohexyl, cyclopentylmethyl, 4fluorocyclohex-3-enyl, 3-fluorophenyl, tetrahydrofur-2-yl, pyrrolidin-1-yl, 4-methyltetrahydropyran-4-yl or thien-2-yl; RI represents hydrogen or fluoro; R2 represents methyl-isoxazolyl, methyl-pyrazolyl, methylimidazolyl, benzimidazolyl or methyl-triazolyl; provided that, when Z represents 1-methylcyclobutyl, R1 is hydrogen and R2 represents 1-methyl-1H-1,2,4-triazol-3-yl or 2-methyl-2H-1,2,4-triazol3-yl, then the fluorine atom is not at the 2-position of the phenyl ring. Also described is a pharmaceutical composition of formula (I) that is useful for the treatment of anxiety, convulsions and migraines.
Patent NZ-509908-A (NZ)
Title: Method for treating inflammation comprising loteprednol etabonate and cellulose carmellose
Inventor: DOI KOJI
IPC: A61K31/56
Filed: 1998-01-14
Abstract: A method for treating inflammation or allergy in a non-human animal comprises administrating an effective amount of an aqueous suspension for nasal administration comprising loteprednol etabonate and microcrystalline cellulose carmellose sodium to nasal mucosa. (62) Divided out of 336990
Patent NZ-517556-A (NZ)
Title: N-[o-(p-pivaloyloxybenzenesulphonyl-amino)benzoyl]glycine as preventive and therapeutic agents for eye diseases
Inventor: NAKA HIROAKI
IPC: A61K47/04
Filed: 2000-09-05
Abstract: A prophylactic and therapeutic medicament is disclosed for ophthalmic diseases, especially ophthalmic inflammatory diseases such as keratoconjunctival inflammatory diseases and corneal ulcer such as infectious corneal ulcer, comprising as an active ingredient a compound represented by the formula (I): or a pharmacologically acceptable salt or hydrate thereof.
Patent NZ-520799-A (NZ)
Title: Modified factor VIII
Inventor: LOLLAR JOHN S
IPC: A61K38/00
Filed: 2001-02-16
Abstract: A modified form of porcine factor VIII that does not have a B-domain, DNA encoding the same, and the use thereof for treatment of hemophilia.
Patent NZ-523438-A (NZ)
Title: Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
Inventor: BECKER MARK W
IPC: A61K31/675
Filed: 2001-07-20
Abstract: A compound of general formula (1) where Ra is H or methyl; a composition comprising the compound and a pharmaceutically effective excipient; and the use of the compound in the preparation of a medicament for antiviral therapy or prophylaxis in a subject in need of such therapy or prophylaxis.
Patent NZ-524252-A (NZ)
Title: Cox-2 inhibitors for treating HIV and AIDS
Inventor: TASKEN KJETIL
IPC: A61P37/02
Filed: 2001-07-20
Abstract: Use of a cyclooxygenase-2 (COX-2) inhibitor which inhibits the enzymatic activity of COX-2 in the preparation of a medicament for treating or preventing HIV or AIDs, or infection by a related virus in a non-human animal such as SIV or FIV.
Patent NZ-524395-A (NZ)
Title: Anticonvulsant and central nervous system-active bis(fluorophenyl) alkylamides
Inventor: BALANDRIN MANUEL F
IPC: A61P25/28
Filed: 1998-12-09
Abstract: Disclosed are compounds of formula (I), wherein: Y is H, F or Cl, X is -NR1R2 or -OR1, R1 is H, alkyl or hydroxyalkyl, R2 is H, methyl or ethyl, and n is from 0-4. The compounds are used in the manufacture of medicaments for the treatment of neurological disorders. (62) Divided out of 504684
Patent NZ-525239-A (NZ)
Title: Sealed back pressure breathing device
Inventor: O'ROURKE SAM
IPC: A61M16/06
Filed: 2001-10-24
Abstract: A hand-held breathing device (10) for use by patients having respiratory problems creates a sealed backpressure in the airways of the patient by creating resistance to exhalation. A peep valve (50) is mounted inside a hollow body, and a pre-set compression spring (40) is mounted between the valve (50) and an adjustable cap (24) or cam lever (78) in the main body of the device (10). A pair of valve openings extend through the wall of the main body, one opening serving as an intake port (42) for inhaling of air by the patient and the second port (44) - for exhalation of carbon dioxide. An intake valve (60) is mounted inside the body between a normally open end of the device (10) and the exhalation valve (50). In one of the embodiments, the device is attached to a nebulizer (88) to facilitate buildup of positive pressure and delivery of medication (104) to the patient's lungs.
Patent NZ-525835-A (NZ)
Title: Infrared (IR) absorbing polyvinyl butyral composition, sheets and glass laminates containing the same as an interlayer
Inventor: FISHER W KEITH
IPC: B32B27/36
Filed: 2001-11-14
Abstract: A polyvinyl butyral composition is disclosed which is comprised of polyvinyl butyral resin containing an infrared (IR) absorbing effective amount of lanthanum hexaboride or a mixture of lanthanum hexaboride and at least one of indium tin oxide and antimony tin oxide. Also disclosed are a sheet of the IR absorbing polyvinyl butyral and a glass laminate having the IR absorbing polyvinyl butyral sheet disposed between two sheets of glass.
Patent NZ-527189-A (NZ)
Title: Peptide compounds for use in prophylactic and therapeutic treatment of NO-mediated diseases
Inventor: SHIMA ICHIRO
IPC: A61P31/04
Filed: 2001-12-18
Abstract: Described is a compound of the formula (I) wherein R1 is benzofuranyl substituted by halogen, or styryl substituted by halogen; R2 is substituted hydroxy, substituted mercapto or substituted sulfonyl; and X is or pharmaceutically acceptable salts thereof. The compound (I) and pharmaceutically acceptable salts thereof possess a strong inhibitory activity on the production of nitric oxide (NO), and are useful for prevention and/or treatment of NO-mediated diseases in animals.
Patent NZ-527434-A (NZ)
Title: Production of protein composition from a dairy stream and its use as an ingredient in the manufacture of a cheese
Inventor: WILES PETER GILBERT
IPC: A23C19/06
Filed: 2003-08-07
Abstract: A process for the manufacture of a protein composition from a dairy stream which comprises the following steps: subjecting the dairy stream to conditions which cause the formation of a protein concentrate and serum, separating the protein concentrate and serum, solubilising the separated protein concentrate in an aqueous solution, combining the solubilised protein concentrate with the separated serum to form the protein composition, and finally concentrating the protein composition. This process is used in the manufacture of cheese.
Patent NZ-529612-A (NZ)
Title: Anti-NGF antibodies for the treatment of various disorders
Inventor: SHELTON DAVID L
IPC: A61K45/00
Filed: 2002-05-09
Abstract: A pharmaceutical composition comprises a chimeric, humanized or human anti-human NGF (anti-hNGF) monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range and inhibiting the binding of hNGF to human TrkA (hTrkA) in vivo and a pharmaceutical acceptable carrier. The antibody has significant adverse effect on the immune e system of a patient. The composition is suitable for the treatment of an inflammatory condition such as multiple sclerosis, arthritis, lupus erythematosus and psoriasis.
Patent NZ-531530-A (NZ)
Title: Compositions and methods for priming monocytic dendritic cells and T cells for TH-1 response using BCG and IFN gamma
Inventor: BOSCH MARNIX L
IPC: G06K19/00
Filed: 2002-09-06
Abstract: A method for producing a mature dendritic cell population comprising: (a) providing immature dendritic cells; and (b) contacting the immature dendritic cells with an effective amount of BCG and Interferon gamma under culture conditions suitable for the maturation of the immature dendritic cell population to form a mature dendritic cell population; wherein the mature dendritic cell population produces an increased ratio of Interleukin 12 to Interleukin 10 than an immature dendritic cell population not contacted with BCG and Interferon gamma during maturation. Also described are compositions for activating T cells; methods for producing T cells; isolated, mature dendritic cells producing more Interleukin 12 to Interleukin 10; methods for producing a type 1 immune response.
Patent NZ-531765-A (NZ)
Title: Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
Inventor: AMICI RAFFAELLA
IPC: C07D413/12
Filed: 2002-09-19
Abstract: Disclosed are aminoindazole compound of formula (I), wherein: R is -NHR', -NR'R", -NHCOR', -NHCONHR', -NHCONR'R", -NHSO2R', -NHCOOR', or a phthalimido group, R1 if present is in position 5 or 6, and represents an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, aryl, aryl-alkyl, heterocyclyl, or heterocyclyl-alkyl, The compounds are used in the manufacture of medicaments for the treatment of diseases associated with altered protein kinase activity, such as cancer, Alzheimer's disease, viral infections, auto-immune disease and neurodegenerative disorders.
Patent NZ-533818-A (NZ)
Title: Polymer for binding of organic molecules or metal ions
Inventor: PETCU MIRUNA
Filed: 2004-06-29
Abstract: Disclosed is an imprinted polymer and a method of preparing it, imprinted with an organic molecule or a metal ion, wherein the matrix of the polymer has been prepared from one or more monomers including bilirubin or biliverdin. Also disclosed are methods for the detection or assay of a compound or a metal ion comprising: contacting the sample to be tested with a polymer as disclosed imprinted with the ion or the molecule or an analogue or derivative thereof; and measuring binding of the molecule to the polymer.
Patent NZ-534544-A (NZ)
Title: N- {5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl} -4-(3-pyridyl)-2-pyrimidine-amine coated stents
Inventor: PRESCOTT MARGARET FORNEY
IPC: A61F2/00
Filed: 2003-02-27
Abstract: Disclosed is a drug delivery device or system comprising i) a medical device adapted for local application or administration in hollow tubes and ii) a therapeutic dosage of N-{5-[4-(4-methyl-piperazino-methyl}-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine or a pharmaceutically acceptable salt or crystal form thereof (Imatinib mesylate) being releasably affixed to the drug delivery device or system.
Patent NZ-539563-A (NZ)
Title: Ring with blood sampling for DNA analysis
Inventor: TEYCHENE BRUNO
IPC: A01K11/00
Filed: 2003-10-21
Abstract: Disclosed is a device for marking and identifying animals comprising a male tag with a punch passing through the animal's ear and penetrating into a hollow head (2) of a female tag (1) under the action of a clamp (not shown). The disclosure is stated to be characterized in that one of the male or female tags is provided with a means (7), lateral to label and detachable therefrom, for sampling biological material extracted from the animal's ear wall when it is pieced by the punch, said sampling means including an absorbent material (9), and in that said means (7) is linked to one of the jaws (not shown) of the clamp and the opening of the clamp jaws and/or its removal from the animal's ear separates the sampling means (7) from the tag concerned (1).
Patent NZ-542437-A (NZ)
Title: Composition comprising cysteamine for improving lactation in dairy animals
Inventor: CHI FRANCIS
IPC: A23K1/16
Filed: 2002-09-18
Abstract: Disclosed herein is a lactation improving feed, comprising an encapsulated composition including (i) cysteamine or a salt thereof and (ii) a stabilizer and/or a coated carrier, for improving lactation of animals. (62) Divided Out of 532176
Patent NZ-542513-A (NZ)
Title: System and method for partial intraframe encoding for wireless multimedia transmission
Inventor: LANE RICHARD DOIL
IPC: H04N7/26
Filed: 2004-03-17
Abstract: A communication system comprises: a processor receiving multimedia data and undertaking logic. The processor partitions the multimedia data into interframe information and intraframe information and establishes at least N hybrid frames at least in part by establishing at least one hybrid frame to have information representing at least one predetermined cyclic intraframe portion and at least some interframe information.